SCHEMBL3607514

SCHEMBL3607514

Oc1ccccc1-c1cc(-c2nnn[nH]2)c(-c2ccccc2O)s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.36
ALOX15 P16050 2/20 0.35
ADORA2A P29274 1/20 0.35
ESR1 P03372 2/20 0.35
GUSB P08236 1/20 0.34
DCUN1D1 Q96GG9 2/20 0.33
MEN1 O00255 3/20 0.33
NPC1 O15118 3/20 0.33
KMT2A Q03164 3/20 0.33
RAB9A P51151 2/20 0.33
HPGD P15428 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP2C19 P33261 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
BRD4 O60885 1/20 0.33
NR1I2 O75469 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30554760 0.80 IDO1 (0.52) IDO1ALOX15ADORA2AGUSBDCUN1D1
SCHEMBL30554759 0.80 IDO1 (0.52) IDO1ALOX15ADORA2AGUSBDCUN1D1
SCHEMBL1773419 0.80 IDO1 (0.52) IDO1ALOX15ADORA2AGUSBDCUN1D1
SCHEMBL3605747 0.79 KDM4E (0.38) ALOX15ESR1MEN1NPC1KMT2A
SCHEMBL3598559 0.75 SLC6A3 (0.42) MEN1KMT2AHPGDCYP1A2CYP2C9
SCHEMBL12496562 0.75 HSD17B1 (0.35) ESR1DCUN1D1HSD17B1
SCHEMBL3604357 0.74 ESR1 (0.61) ESR1HSD17B1GSK3BMAPTSNCA
SCHEMBL6849506 0.74 ALDH1A1 (0.48) IDO1ALOX15ADORA2AGUSBDCUN1D1
SCHEMBL3596099 0.74 HSD17B1 (0.64) ESR1CYP2C9HSD17B1MAPTSNCA
SCHEMBL3363233 0.74 HPGD (0.44) IDO1ALOX15ADORA2ADCUN1D1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 IDO1 2114/4885ALOX15 96/4885ADORA2A 971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.